These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

284 related items for PubMed ID: 24717626

  • 1. Tadalafil in patients with chronic obstructive pulmonary disease: a randomised, double-blind, parallel-group, placebo-controlled trial.
    Goudie AR, Lipworth BJ, Hopkinson PJ, Wei L, Struthers AD.
    Lancet Respir Med; 2014 Apr; 2(4):293-300. PubMed ID: 24717626
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Azithromycin maintenance treatment in patients with frequent exacerbations of chronic obstructive pulmonary disease (COLUMBUS): a randomised, double-blind, placebo-controlled trial.
    Uzun S, Djamin RS, Kluytmans JA, Mulder PG, van't Veer NE, Ermens AA, Pelle AJ, Hoogsteden HC, Aerts JG, van der Eerden MM.
    Lancet Respir Med; 2014 May; 2(5):361-8. PubMed ID: 24746000
    [Abstract] [Full Text] [Related]

  • 6. Clinical efficacy of phosphodiesterase-5 inhibitor tadalafil in Eisenmenger syndrome--a randomized, placebo-controlled, double-blind crossover study.
    Mukhopadhyay S, Nathani S, Yusuf J, Shrimal D, Tyagi S.
    Congenit Heart Dis; 2011 May; 6(5):424-31. PubMed ID: 21914136
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Efficacy and safety of RPL554, a dual PDE3 and PDE4 inhibitor, in healthy volunteers and in patients with asthma or chronic obstructive pulmonary disease: findings from four clinical trials.
    Franciosi LG, Diamant Z, Banner KH, Zuiker R, Morelli N, Kamerling IM, de Kam ML, Burggraaf J, Cohen AF, Cazzola M, Calzetta L, Singh D, Spina D, Walker MJ, Page CP.
    Lancet Respir Med; 2013 Nov; 1(9):714-27. PubMed ID: 24429275
    [Abstract] [Full Text] [Related]

  • 9. Effects of tadalafil treatment on erectile function recovery following bilateral nerve-sparing radical prostatectomy: a randomised placebo-controlled study (REACTT).
    Montorsi F, Brock G, Stolzenburg JU, Mulhall J, Moncada I, Patel HR, Chevallier D, Krajka K, Henneges C, Dickson R, Büttner H.
    Eur Urol; 2014 Mar; 65(3):587-96. PubMed ID: 24169081
    [Abstract] [Full Text] [Related]

  • 10. Treatment of patients with mildly symptomatic pulmonary arterial hypertension with bosentan (EARLY study): a double-blind, randomised controlled trial.
    Galiè N, Rubin Lj, Hoeper M, Jansa P, Al-Hiti H, Meyer G, Chiossi E, Kusic-Pajic A, Simonneau G.
    Lancet; 2008 Jun 21; 371(9630):2093-100. PubMed ID: 18572079
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Tadalafil therapy and health-related quality of life in pulmonary arterial hypertension.
    Pepke-Zaba J, Beardsworth A, Chan M, Angalakuditi M.
    Curr Med Res Opin; 2009 Oct 21; 25(10):2479-85. PubMed ID: 19686085
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Efficacy and treatment satisfaction with on-demand tadalafil (Cialis) in men with erectile dysfunction.
    Skoumal R, Chen J, Kula K, Breza J, Calomfirescu N, Basson BR, Kopernicky V.
    Eur Urol; 2004 Sep 21; 46(3):362-9; discussion 369. PubMed ID: 15306109
    [Abstract] [Full Text] [Related]

  • 18. Effects of once-daily tadalafil on treatment satisfaction, psychosocial outcomes, spontaneous erections, and measures of endothelial function in men with erectile dysfunction but naive to phosphodiesterase type 5 inhibitors.
    Porst H, Brock GB, Kula K, Moncada I, Montorsi F, Basson BR, Kinchen K, Aversa A.
    J Androl; 2012 Sep 21; 33(6):1305-22. PubMed ID: 22790642
    [Abstract] [Full Text] [Related]

  • 19. Efficacy and safety of PDE-5 inhibitor tadalafil in pulmonary arterial hypertension.
    Bharani A, Patel A, Saraf J, Jain A, Mehrotra S, Lunia B.
    Indian Heart J; 2007 Sep 21; 59(4):323-8. PubMed ID: 19126937
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.